A person’s race and ethnicity play a role in who they trust for urologic cancer information, according to a study presented at the 25th Annual Meeting of the Society of Urologic Oncology. The cross-sectional analysis assessed variations among five trusted sources: doctor, family/friends, government health agencies, charitable organizations, and religious organizations. Nearly 350 people with either prostate (n=282), kidney (n=41), or bladder (n=25) cancers were identified from the Health Information National Trends ...
Advertisement
Dr. Luke Twelves Talks Clinical Trials Diversity for Type 2 Diabetes Patients
"I’m passionate about creating systems where primary care and specialists work together more seamlessly."
Less than half of VA hospitals are sites for prostate cancer clinical trials.
Patients who are transgender and gender nonconforming with genitourinary and gynecologic cancers face inequalities in care.
Enrollment falls short by approximately one in 14 women with kidney cancer.
Dr. Von Nguyen, Chief Clinical Officer at Evolent, discusses the use of AI and technology in medicine and population health.
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
Urban Health Weekly
Dr. Luke Twelves Talks Clinical Trials Diversity for Type 2 Diabetes Patients
Dr. Amy McMichael Discusses Plaque Psoriasis on Skin of Color, Johnson & Johnson's VISIBLE Study.
Dr. Daniel Von Hoff on the $150M Stephenson Prize to Advance Pancreatic Cancer Research
Dr. Sherri Onyiego Discusses Value-Based Care for improved healthcare access.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.